<analysis>
**Action 1 (probe and cross-grading pilot).** This is a routine internal pilot that runs on the existing alignment allocation. Claude does the engineering, and humans only review. The real bottleneck is researcher review time. The capacity crunch matters less here because no new compute is requested.
- Realistic failure modes: the leads deprioritise it during release season, or the pilot's scope is too thin to produce a usable memo by month-end.
- The letter to AISI and CAISI only needs to reach government partnerships, which is easy. An MOU in January is not expected, and I do not count it toward success.
- An ambiguous scientific result is modelled separately by Threat 3. Bandwidth being pulled away by a competitor launch is modelled by Threat 4.
- Following the judge's guidance on routine internal pilots, I set this near 25%.

**Action 2 (Safety Commons reshaped).** The comms hold has lapsed, but pre-IPO legal review of an open-source release still takes time.
- Frontier Model Forum co-maintainership moves at committee speed. At most it can be initiated in January.
- The JFrog disclosure package is internal preparation and very feasible.
- Chinese documentation is likely to be deferred again, but that is minor.
- A delay caused by a competitor launch belongs to Threat 4, not here.
- Remaining execution risk is legal or security review of the monitoring pipeline, and the possibility that the Forum fallback stalls on process: about 35%.

**Action 3 (institutional voice).**
- A statement for the record is low-friction, and anyone can submit one.
- Folder cleanup is trivial.
- Voluntarily publishing the RAISE filing during registration is the part most likely to be trimmed by counsel. That would make it a partial success, not a failure.
- Overall about 25%.

**Action 4 (Infrastructure Shield).** The CISA channel and scanning-authorisation problems are already modelled by Threat 1, so they are not counted here.
- Own execution risk:
  - Glasswing and legal must approve an external scanning product.
  - The ISAC must agree to co-brand.
  - Taking the hospital letter of intent to a live deployment in a month is unlikely on its own.
- The fallback guide is achievable but needs a partner.
- About 40%.

**Action 5 (Claude Works narrowed).** Judged against its fallback, the minimum this month is passing the roadmap review with a February plan.
- Removing benefits-application help clears the unauthorised-practice-of-law concern.
- Signing government workforce-board partners in one month is slow, as is identity verification for jobseekers.
- The roadmap review itself could slip or deprioritise the product during a capacity crunch.
- About 35%.

**Threats.**
- **Threat 1:** The CISA cuts are credible and consistent with real 2025 workforce reductions, and ISACs pass along advisories rather than deploy tools. Scanning 50 or more utilities was always a stretch.
- **Threat 2:** Real reporting in early 2026 describes Claude being misused against Mexican government and utility targets, so I accept it as a credible pre-game fact. It only bites if the Shield becomes public and gets noticed.
- **Threat 3:** Evaluation awareness is known to be probeable, so an ambiguous result is quite plausible.
- **Threat 4:** I keep the world state: GPT-6-class is in the CAISI preview with a late-January target, and I treat the unverified Wikipedia snippet as a naming or reporting confusion. A release is likely, but a knock-on delay needs a second step.
- **Threat 5:** An eval shipped in mid-January is very unlikely to be gamed and publicly cited within about two weeks.
</analysis>

<action_odds>
- Action 1 [Probe/cross-grading pilot]: P(failure) 25%. Reason: a routine internal pilot on the existing budget, with Claude doing the engineering. The main risks are review bandwidth and a thin result by month-end. The MOU letter is not required for success.
- Action 2 [Safety Commons reshaped]: P(failure) 35%. Reason: pre-IPO legal and security review of an open-source release and Forum process friction. Competitor-timing delays are modelled in Threat 4, not here.
- Action 3 [Institutional voice / hearing / RAISE]: P(failure) 25%. Reason: a statement for the record and folder cleanup are easy. Counsel trimming the voluntary publication of the RAISE filing is the likeliest partial loss.
- Action 4 [Infrastructure Shield]: P(failure) 40%. Reason: internal approval of an external scanning tool, ISAC co-branding and a hospital deployment within one month. Channel and authorisation problems are modelled in Threat 1.
- Action 5 [Claude Works narrowed]: P(failure) 35%. Reason: passing the roadmap review is feasible now that the unauthorised-practice issue is removed, but government partners and jobseeker verification are slow and capacity is tight.
</action_odds>

<threat_odds>
- Threat 1 [CISA channel gone]: P(materialises) 55%. Adversary suggested 60%. The cuts are credible and the 50-utility target was a stretch. It is slightly lower because the ISAC-guide fallback and a few direct scans remain plausible.
- Threat 2 [Arsonist framing]: P(materialises) 18%. Adversary suggested 25%. The fact is credible, but it needs the Shield to become visible and a critic or witness to connect the two stories within the month.
- Threat 3 [Ambiguous pilot result]: P(materialises) 35%. Adversary suggested 40%. Test-awareness is a genuinely likely finding. It is slightly lower because the pilot may be too small for the result to be treated as a blocking RSP question this month.
- Threat 4 [Competitor release diverts bandwidth]: P(materialises) 35%. Adversary suggested 45%. A GPT-6 or Gemini 4 launch in January is likely (about 65%), but it also has to cause a concrete hold or lost review time, which is less certain. I keep the world-state framing that GPT-6 debuts in January.
- Threat 5 [Public eval gamed]: P(materialises) 6%. Adversary suggested 20%. A suite shipped in mid-January is very unlikely to be contaminated and cited in a model card within weeks. The risk is real later, not this month.
</threat_odds>
